Baroni T, Carinci P, Lilli C, Bellucci C, Aisa MC, Scapoli L, Volinia S, Carinci F, Pezzetti F, Calvitti M, Farina A, Conte C, Bodo M.
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
J Cell Physiol. 2005 Feb;202(2):524-35.
http://www.ncbi.nlm.nih.gov/pubmed/15389579
Bodo M, Lilli C, Bellucci C, Carinci P, Calvitti M, Pezzetti F, Stabellini G, Bellocchio S, Balducci C, Carinci F, Baroni T.
Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation.
Mol Med. 2002 Jul;8(7):393-404.
http://www.ncbi.nlm.nih.gov/pubmed/12393937
Bodo M, Lilli C, Aisa MC, Scapoli L, Bellucci C, Rinaldi E, Tosi L, Baroni T, Conte C, Bellocchio S, Carinci F, Stabellini G, Carinci P.
Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation.
J Interferon Cytokine Res. 2002 Jun;22(6):621-30.
http://www.ncbi.nlm.nih.gov/pubmed/12162872
Bodo M, Baroni T, Carinci F, Becchetti E, Bellucci C, Conte C, Pezzetti F, Evangelisti R, Tognon M, Carinci P.
A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon’s syndrome.
Eur J Cell Biol. 1999 May;78(5):323-30.
http://www.ncbi.nlm.nih.gov/pubmed/10384983
Bodo M, Carinci F, Baroni T, Becchetti E, Giammarioli M, Bellucci C, Pezzetti F, Evangelisti R, Carinci P.
Effects of interleukins on Crouzon fibroblast phenotype in vitro. Release of cytokines and IL-6 mRNA expression.
Cytokine. 1996 Oct;8(10):772-83.
http://www.ncbi.nlm.nih.gov/pubmed/8980879
